Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-22 to 2024-01-17
Current total value of award: $7737
Description: 4563201540!XOLAIR 150 MG/ML SYRINGEML